Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
Titel:
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
Auteur:
Meric-Bernstam, Funda Beeram, Muralidhar Hamilton, Erika Oh, Do-Youn Hanna, Diana L Kang, Yoon-Koo Elimova, Elena Chaves, Jorge Goodwin, Rachel Lee, Jeeyun Nabell, Lisle Rha, Sun Young Mayordomo, Jose El-Khoueiry, Anthony Pant, Shubham Raghav, Kanwal Kim, Jin Won Patnaik, Amita Gray, Todd Davies, Rupert Ozog, Mark A Woolery, Joseph Lee, Keun-Wook